 Westport, CT, March 09, 2021 GLOBE NEWSWIRE -- BioSig Technologies, Inc. Nasdaq: BSGM BioSig or the Company, a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it will present at the 33rd Annual Virtual ROTH Conference, being held on March 15-17, 2021. Kenneth L. Londoner, Chairman, and CEO of BioSig Technologies, Inc. will deliver a Company overview and provide updates on recent progress. Mr. Londoner will also be available for investor meetings. 